First Eagle Investment Management
SGMO

First Eagle Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

First Eagle Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,259
Closed -$37K – 345
2015
Q4 		$37K Sell
3,259
-3,258
-50% -$25.1K ﹤0.01% 287
2015
Q3 		$53K Buy
6,517
+2,500
+62% +$20.6K ﹤0.01% 277
2015
Q2 		$133K Hold
4,017
– – ﹤0.01% 259
2015
Q1 		$964K Hold
4,017
– – ﹤0.01% 233
2014
Q4 		$1.29M Buy
4,017
+17
+0.4% +$206 ﹤0.01% 226
2014
Q3 		$620K Buy
4,000
+1,500
+60% +$19.6K ﹤0.01% 247
2014
Q2 		$875K Buy
+2,500
New +$36K ﹤0.01% 236

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

First Eagle Investment Management's SGMO Position: Q3 2016 in Review

First Eagle Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2016, closing a stake of 60,000 shares — an estimated $347K sold.

First Eagle Investment Management first reported a position in SGMO in Q2 2013 and held it in 12 quarters. The position peaked at $11.8M in Q4 2013. 124 funds tracked by Wall St. Rank hold SGMO as of Q3 2016.

  • First Eagle Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • First Eagle Investment Management sold 60,000 SANGAMO THERAPEUTICS INC shares in Q3 2016, an estimated $347K.
  • First Eagle Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 12 quarters.
  • First Eagle Investment Management's SANGAMO THERAPEUTICS INC position peaked at $11.8M in Q4 2013.
  • 124 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2016.

Based on First Eagle Investment Management's 13F filing for Q3 2016, filed 7 Nov 2016.